1 / 1

Jain RK et al. (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer

Table 3 Completed Phase III trials for multi-targeted agents with VEGF receptor 2 kinase as one of their targets. Jain RK et al. (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer Nat Clin Pract Oncol 3: 24 –40 doi:10.1038/ncponc0403.

veda-giles
Télécharger la présentation

Jain RK et al. (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Table 3 Completed Phase III trials for multi-targeted agents with VEGF receptor 2 kinase as one of their targets Jain RK et al. (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer Nat Clin Pract Oncol 3: 24–40 doi:10.1038/ncponc0403

More Related